Shares of BioCorRx Inc. (OTCMKTS:BICX – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.08 and traded as low as $0.82. BioCorRx shares last traded at $0.82, with a volume of 7,500 shares.
BioCorRx Stock Performance
The stock has a fifty day simple moving average of $1.02 and a 200-day simple moving average of $1.08. The stock has a market cap of $7.28 million, a P/E ratio of -1.82 and a beta of 0.59.
BioCorRx (OTCMKTS:BICX – Get Free Report) last posted its quarterly earnings data on Monday, April 1st. The company reported ($0.11) earnings per share (EPS) for the quarter. The company had revenue of $0.02 million during the quarter.
BioCorRx Company Profile
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Read More
- Five stocks we like better than BioCorRx
- What Are the U.K. Market Holidays? How to Invest and Trade
- High-Yield Texas Instruments Could Hit New Highs Soon
- What Does Downgrade Mean in Investing?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- What is a Dividend King?
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for BioCorRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioCorRx and related companies with MarketBeat.com's FREE daily email newsletter.
